FDA Reviewing Preliminary Safety Information on Actos (pioglitazone)
Links shared publicly online about this topic.
- 835total visits
FDA Reviewing Preliminary Safety Information on Actos (pioglitazone)
View full resource at diabetesincontrol.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, FDA, Actos, Safety
Most Recently Shared on September 30, 2010 at 3:46 pm By:
FDA Reviewing Preliminary Safety Information on Actos (pioglitazone) http://t.co/owEq4cN via @AddThis
Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer
fda.gov — “FDA reviewing preliminary results on five-year data from an ongoing, 10-year observational epidemiological study.” View full resource at fda.gov
Most Recently Shared on February 21, 2011 at 8:40 pm By:
madan kwatra PhD and Doctor
Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer http://t.co/8p9B2IZ via @AddThis
FDA Reviewing Preliminary Safety Information On Actos (pioglitazone) | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “FDA Reviewing Preliminary Safety Information On Actos (pioglitazone) | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 20, 2010 at 9:38 pm By:
FDA Reviewing Preliminary Safety Information On Actos (pioglitazone): The U.S. Food and Drug… http://goo.gl/fb/M6Cz7
FDA Reviewing Preliminary Safety Information on Actos (pioglitazone) - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary result” View full resource at drugs.com
Most Recently Shared on September 20, 2010 at 2:16 pm By:
Drugs and Devices OW OW Health
FDA Reviewing Preliminary Safety Information on Actos (pioglitazone): SILVER SPRING, Md., Sept. 17 /PRNewswir... http://bit.ly/dctUns #drug
FDA reviewing preliminary safety information on Actos (pioglitazone) - Pharma Marketing Network Forums
forums.pharma-mkting.com — “FDA reviewing preliminary safety information on Actos (pioglitazone) Regulatory Affairs” View full resource at forums.pharma-mkting.com
Most Recently Shared on September 18, 2010 at 4:08 pm By:
FDA reviewing preliminary safety information on Actos: http://bit.ly/9h0YOB
FDA Reviewing Preliminary Safety Information On Actos (pioglitazone)
medicalnewstoday.com — “The U.S. Food and Drug Administration announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study des” View full resource at medicalnewstoday.com
Most Recently Shared on September 18, 2010 at 2:05 pm By:
FDA Reviewing Preliminary Safety Information On Actos (pioglitazone) http://mnt.to/3K23 #diabetes
FDA reviews Actos drug for bladder cancer risk
news-medical.net — “The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.” View full resource at news-medical.net
Most Recently Shared on September 18, 2010 at 4:29 am By:
FDA reviews Actos drug for bladder cancer risk: The U.S. Food and Drug Administration today announced it has begun... http://bit.ly/bKwtuu
Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer
fda.gov — “FDA reviewing preliminary results on five-year data from an ongoing, 10-year observational epidemiological study.” View full resource at fda.gov
Most Recently Shared on September 17, 2010 at 7:53 pm By:
madan kwatra PhD and Doctor
Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer http://t.co/EwWFq9h
FDA reviewing preliminary safety information on Actos http://ow.ly/2FYe9
fda.gov — “FDA reviewing preliminary safety information on Actos http://ow.ly/2FYe9” View full resource at fda.gov
Most Recently Shared on September 17, 2010 at 6:26 pm By:
eyeonfda Pharma and Health Lawyer
FDA reviewing preliminary safety information on Actos http://ow.ly/2FYe9
Advertisement
